BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 15471223)

  • 1. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
    Tomer A
    J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombogenesis in sickle cell disease.
    Tomer A; Harker LA; Kasey S; Eckman JR
    J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
    Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
    J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of activated platelets in canine blood by use of flow cytometry.
    Wills TB; Wardrop KJ; Meyers KM
    Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPV is a marker of in vivo platelet activation--study in a rat thrombosis model.
    Ravanat C; Freund M; Mangin P; Azorsa DO; Schwartz C; Moog S; Schuhler S; Dambach J; Cazenave JP; Lanza F
    Thromb Haemost; 2000 Feb; 83(2):327-33. PubMed ID: 10739394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation.
    Vidal C; Spaulding C; Picard F; Schaison F; Melle J; Weber S; Fontenay-Roupie M
    Thromb Haemost; 2001 Sep; 86(3):784-90. PubMed ID: 11583308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
    Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
    Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
    Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of platelet function by flow cytometry.
    Michelson AD; Barnard MR; Krueger LA; Frelinger AL; Furman MI
    Methods; 2000 Jul; 21(3):259-70. PubMed ID: 10873480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection method for platelet activation markers].
    Satoh K; Yatomi Y; Ozaki Y
    Rinsho Byori; 2002 Aug; 50(8):773-8. PubMed ID: 12373813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.
    Tomer A; Kasey S; Connor WE; Clark S; Harker LA; Eckman JR
    Thromb Haemost; 2001 Jun; 85(6):966-74. PubMed ID: 11434703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate-intensity exercise suppresses platelet activation and polymorphonuclear leukocyte interaction with surface-adherent platelets under shear flow in men.
    Wang JS; Liao CH
    Thromb Haemost; 2004 Mar; 91(3):587-94. PubMed ID: 14983236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet hyporeactivity in very low birth weight neonates.
    Rajasekhar D; Barnard MR; Bednarek FJ; Michelson AD
    Thromb Haemost; 1997 May; 77(5):1002-7. PubMed ID: 9184418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometric 3-color analysis of circulating activated platelets and its clinical significance in ischemic cerebrovascular diseases].
    Wang J; Cao L; He M
    Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):499-502. PubMed ID: 11798806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of platelet glycoprotein IIb/IIIa and P-selectin, and neutrophil-platelet interaction in human coronary unstable plaques.
    Ikuta T; Naruko T; Ikura Y; Ohsawa M; Fukushima H; Shirai N; Itoh A; Haze K; Ehara S; Sasaki Y; Shibata T; Suehiro S; Ueda M
    Int J Mol Med; 2005 Apr; 15(4):573-7. PubMed ID: 15754016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
    Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
    Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet surface P-selectin molecules increased after exposing platelet to a high shear flow.
    Goto S; Ichikawa N; Lee M; Goto M; Sakai H; Kim JJ; Yoshida M; Handa M; Ikeda Y; Handa S
    Int Angiol; 2000 Jun; 19(2):147-51. PubMed ID: 10905798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation after stenting with heparin-coated versus noncoated stents.
    Gurbel PA; Bliden KP
    Am Heart J; 2003 Oct; 146(4):E10. PubMed ID: 14564333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in platelet membrane glycoproteins before bone marrow transplantation and after engraftment--a pilot study.
    Neumeister P; Hiller E; Gawaz M; Holler E; Kolb HJ; Sill H; Pihusch R; Mempel W; Wittmann G; Salat C
    Eur J Med Res; 1998 Oct; 3(10):465-9. PubMed ID: 9753703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of surface membrane proteins on activated platelets and platelet-derived microparticles from healthy and thrombasthenic individuals.
    Nomura S; Komiyama Y; Murakami T; Funatsu A; Kokawa T; Sugo T; Matsuda M; Yasunaga K
    Int J Hematol; 1993 Oct; 58(3):203-12. PubMed ID: 8148498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.